minoxidil has been researched along with Triple Negative Breast Neoplasms in 1 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, S | 1 |
| Fraser, SP | 1 |
| Pires, W | 1 |
| Djamgoz, MBA | 1 |
1 other study available for minoxidil and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine.
Topics: Adenosine Triphosphate; Cell Line, Tumor; Humans; Ion Channels; Minoxidil; Ranolazine; Triple Negati | 2022 |